|
Respondents* |
Mean score (SD) |
Clinically significant symptoms† |
|
|---|---|---|---|
|
Depression (PHQ‐9) |
|||
|
28–31 March (baseline) |
1295 |
5.4 (5.9) |
263 (20.3%) |
|
11–16 April |
969 |
5.8 (6.3) |
229 (23.6%) |
|
25–30 April |
949 |
5.6 (6.1) |
208 (21.9%) |
|
9–14 May |
907 |
5.2 (5.8) |
195 (21.5%) |
|
23–28 May |
871 |
4.9 (5.6) |
167 (19.2%) |
|
6–11 June |
812 |
4.7 (5.6) |
154 (19.0%) |
|
20–25 June |
758 |
4.8 (5.7) |
139 (18.3%) |
|
Anxiety (GAD–7) |
|||
|
28–31 March (baseline) |
1295 |
4.4 (5.2) |
212 (16.4%) |
|
11–16 April |
969 |
4.6 (5.2) |
164 (16.9%) |
|
25–30 April |
950 |
4.4 (5.1) |
163 (17.2%) |
|
9–14 May |
907 |
4.1 (4.9) |
137 (15.1%) |
|
23–28 May |
871 |
3.8 (4.7) |
112 (12.9%) |
|
6–11 June |
812 |
3.7 (4.7) |
104 (12.8%) |
|
20–25 June |
758 |
3.8 (4.8) |
102 (13.5%) |
GAD‐7 = Generalized Anxiety Disorder assessment; PHQ‐9 = Patient Health Questionnaire; SD = standard deviation.
That is, participants who provided responses to PHQ‐9 and GAD‐7 questions.
Scores of 10 points or more.